- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01643538
Social Goals and Individual Incentives to Promote Walking in Older Adults
Social Goals and Individual Incentives to Promote Walking in Older Adults (Way to Walk II)
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- University of Pennsylvania
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Adult 65 years of age and older
- Can read and speak English
- Access to a personal computer with high-speed internet connection and functional Universal Serial Bus (USB) port for the study duration
- Able to walk 1/4 mile (i.e., 2 to 3 blocks) without stopping
- No pedometer use in last 30 days
Exclusion Criteria:
Major medical conditions including:
- serious heart and lung diseases
- diabetes requiring insulin therapy
- severe arthritis
- neurologic disorders
- dementia
- heavy alcohol use
- recent knee or spinal surgery
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Control Arm
Daily use of pedometer for 5 months. Walking goal set based on level of walking during 2-week run-in period. Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week. Subjects in the Control Group will only receive pedometers and weekly feedback on their performance through the same mechanisms and with the same frequency as participants in the other three study arms. There will be no financial incentives or charity donations in this group. |
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
|
|
Eksperimentel: Personal Financial Incentives Arm
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Each week, if pedometer is used and walking goal is met for 5 out of 7 days, participant will receive $20. Financial incentive is terminated after 4 months.
Daily use of pedometer continues for an additional 4 weeks.
|
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Participants will receive a direct financial incentive in the amount of $20 for each week when their daily pedometer step count equals or exceeds their goal at least 5 out of 7 days.
|
|
Eksperimentel: Social Goals Arm
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Each week participants will be asked to designate which charity should receive a donation if they meet or exceed their goal.
If they meet the goal, they will be notified that a donation of $20 in their name has been sent to the charity.
Charity donation is terminated after 4 months.
Daily use of pedometer continues for an additional 4 weeks.
|
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Participants will be asked to identify a charity to which they would like to donate the payment for reaching their walking goal.
Each week they will be asked to designate which charity should receive a donation if they meet or exceed their goal.
If they meet the goal, they will be notified that a donation of $20 in their name has been sent to the charity.
|
|
Eksperimentel: Combined Financial Incentives & Social Goals Arm
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Each week, the participant will be asked to choose whether to keep, give, or split the reward, if they meet or exceed their goal.
If they choose to send some of the money to charity, they will be asked to identify a charity to which they would like to donate the payment.
If they meet their goal, they will receive money and/or be notified that a donation of the selected amount has been sent to the charity, depending on their selected preference.
Incentives are terminated after 4 months.
Daily use of pedometer continues for an additional 4 weeks.
|
Daily use of pedometer for 5 months.
Walking goal set based on level of walking during 2-week run-in period.
Weekly feedback provided on meeting walking goal - defined as achieving goal number of steps for 5 of 7 days per week.
Participants will be able to allocate their reward for reaching their walking goal: the $20 reward can be divided between personal financial incentive and a charitable donation.
Each week, the participant will be asked to choose whether to keep, give, or split the reward, if they meet or exceed their goal.
If they choose to send some of the money to charity, they will be asked to identify a charity to which they would like to donate the payment.
If they meet their goal, they will be notified by email or mail (based on their preference), that a donation of the selected amount has been sent to the charity.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
mean proportion of days that step per day goals were attained
Tidsramme: 16 weeks
|
16 weeks
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
mean number of steps per day
Tidsramme: 16 weeks
|
16 weeks
|
|
mean proportion of days that step per day goals were attained during follow-up
Tidsramme: 4 weeks
|
4 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Karen Glanz, PhD, MPH, University of Pennsylvania
- Ledende efterforsker: Jason Karlawish, MD, University of Pennsylvania
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 69924
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Fysisk aktivitet
-
University of ValenciaAktiv, ikke rekrutterendeAutismespektrumforstyrrelse | Attention Deficit Hyper ActivitySpanien
-
NYU Langone HealthAfsluttetAttention Deficit Hyper ActivityForenede Stater
-
Texas Woman's UniversityAfsluttetIntellektuel handicap | Autismespektrumforstyrrelse | Motoriske lidelser | Motorforsinkelse | Sanseforstyrrelser | Attention Deficit Hyper Activity
-
Cingulate TherapeuticsPremier Research Group plcAfsluttetADHD | Attention Deficit Hyperactivity Disorder | ADHD - kombineret type | Attention Deficit Hyperactivity Disorder kombineret | Attention Deficit Hyper Activity | Opmærksomhedsunderskud hyperaktivitetForenede Stater
-
Cingulate TherapeuticsSuspenderetADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder med hyperaktivitet | ADHD - kombineret type | Attention Deficit Hyperactivity Disorder kombineret | Attention Deficit Hyper Activity | Opmærksomhedsunderskud hyperaktivitetForenede Stater
-
Affiliated Hospital to Academy of Military Medical...Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking...RekrutteringAldersinterval ≥16 år, køn ubegrænset | Histopatologi bekræftet diffust stort B-celle lymfom eller højgradigt B-celle lymfom | Modtaget tidligere førstelinjekemoterapi for DLBCL eller HGBL, kunne ikke nå CR i fire cyklusser eller tilbagefald | Mindst én positiv læsion ifølge 2014 Lugano-kriterierne... og andre forholdKina